David Geffen School of Medicine at UCLA
Cedars-Sinai Medical Center
Charles R. Drew University of Medicine and Science
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
We do not support your browser. Please take a moment and
upgrade to the most recent version
of Internet Explorer.
Researcher Resources
Education & Training
Community Engagement
Funding
About
Log In or Register
•
CTSI Faculty Search
•
Quick Links
Main
CTSI Distinguished
Speaker Series
Human Subjects &
Clinical Trials Updates
Letter of Support
Research Cores
Boilerplate Text
Grant Library
Clinical & Translational Research Centers
Trial Innovation
Network
Clinical Data Requests
Therapeutic Antibody Lab
Events
view all
JAN 29
Antisense Oligonucleotide-Based Therapies for Neurological Diseases - C. Frank Bennett, Ph.D., Ionis Pharmaceuticals
JAN 29
Drop-In Statistical Consults at UCLA
JAN 30
Grants Submission Unit and Trial Innovation Network Office Hours
JAN 30
Using A Learning Network Approach to Improve the Health of Communities
JAN 31
Medical Device Forum on Innovation and Education: Patenting Medical Devices
JAN 31
Medical Device Forum on Innovation and Education: Patenting Medical Devices
JAN 31
CDI Seminar: The Learning Health System: Strategies for Transformation and Building Capability
JAN 31
Drop-In Statistical Consults at UCLA
CTSI Distinguished Speaker Series
Deadlines
view all
JAN 29
UC CRCC Funding Opportunities
JAN 30
Design Lab Opportunity – Call for Brief Proposals
FEB 01
Inaugural California Precision Health Summit: Free Registration for Students & Trainees!
FEB 06
NCATS Funding Opportunity to Address Ethical Issues in Translational Science Research
MAR 01
UCLA Neurodegenerative Diseases Symposium - Register and/or Submit Abstacts
MAR 01
Accepting Applications for mHealth Training Institute 2.0
MAR 12
UCLA CTSI TL1 Health Systems Science Summer Fellowship for Health Professional Students
MAR 24
NIH Heal Opportunity in Pain Management Effectiveness Research
News
archive
UCLA and Cedars-Sinai Researchers Receive the First Food Allergy Seed Grants
Sixth Annual DHS Diabetes Day Draws Largest Audience to Date
New Drug Targets Breast Cancer Cells
Researchers Create Accurate Model of Organ Scarring Using Stem Cells in a Lab
New NIH Application Guidelines Coming in 2020
Antisense Oligonucleotide-Based Therapies for Neurological Diseases - C. Frank Bennett, Ph.D., Ionis Pharmaceuticals
